证券代码：301128 证券简称：强瑞技术 公告编号：2025-037 深圳市强瑞精密技术股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏 一、会议召开情况 深圳市强瑞精密技术股份有限公司（以下简称"公司"）第二届监事会第二 十次（临时）会议通知于 2025 年 5 月 30 日以电子邮件、电话通知等方式发出， 于 2025 年 6 月 4 日在深圳市龙华区观湖街道樟坑径社区安澜路 308 号 C 栋厂房 人，其中赵迪先生以通讯表决方式参加。会议由监事会主席赵迪先生主持。本次 监事会会议的召开符合有关法律、行政法规、部门规章、规范性文件和公司章程 的规定。 二、会议审议情况 (一)审议通过了《关于使用闲置募集资金暂时补充流动资金的议案》 于使用闲置募集资金暂时补充流动资金的议案》。经审核，监事会认为公司在确 保募集资金安全、操作合法合规、保证募投项目建设不受影响的情况下，使用闲 置募集资金暂时补充流动资金,有利于满足公司日常经营需要，有利于提高募集 资金的使用效率，降低财务费用，符合公司发展需要和全体股东利益。审议程序 符合《上市公司自律监管指引第 ...

Core Points - The company held its 16th meeting of the 8th Board of Directors on May 30, 2025, with all 9 directors present, confirming the legality and validity of the meeting [1] - The Board approved the use of up to 100 million yuan of idle raised funds to temporarily supplement working capital for a period not exceeding 12 months, ensuring the funds are used for operations related to the company's main business [1] - The Board also approved the establishment of dedicated accounts for raised funds at three banks to enhance fund management and protect shareholder interests [2]

Core Viewpoint - The company has approved the temporary use of idle raised funds to supplement working capital, with specific amounts and timeframes outlined in multiple announcements [1][2][3]. Group 1: Fund Usage Approvals - On December 3, 2024, the company approved the use of up to 400 million yuan of idle raised funds for temporary working capital, with a usage period not exceeding 12 months [1]. - On December 30, 2024, the company approved the use of up to 300 million yuan of idle raised funds for temporary working capital, with a similar usage period [2]. - On May 20, 2025, the company approved the use of up to 80 million yuan of idle raised funds for temporary working capital, also with a maximum usage period of 12 months [3]. Group 2: Fund Return Status - As of the latest updates, 30 million yuan from the 400 million yuan approved on December 3, 2024, has been returned to the dedicated fundraising account, with 370 million yuan remaining [3]. - From the 300 million yuan approved on December 30, 2024, 295 million yuan remains unreturned [3]. - The 80 million yuan approved on May 20, 2025, has not yet been utilized, totaling 665 million yuan of idle raised funds that will be returned before the expiration date [3].

Group 1 - The company held its 17th meeting of the 8th Supervisory Board on May 23, 2025, with three supervisors present, and the meeting was legally valid [1] - The Supervisory Board approved the proposal to temporarily use part of the idle raised funds to supplement working capital, which is expected to enhance the efficiency of fund usage and reduce financial costs [2] - The company is authorized to use up to RMB 400 million of idle raised funds for a period not exceeding 12 months from the date of approval by the Board, without affecting the normal operation of the investment projects [2]

一、募集资金基本情况 经中国证券监督管理委员会《关于同意浙江东南网架股份有限公司向不特定 对象发行可转换公司债券注册的批复》（证监许可〔2023〕1845 号）同意注册， 公司于 2024 年 1 月 3 日向不特定对象发行可转换公司债券 2,000 万张，每张面 值为人民币 100 元，按面值发行，本次发行的募集资金总额为人民币 200,000.00 万元，扣除各项发行费用（不含增值税）人民币 13,768,519.87 元后，实际募集 资金净额为人民币 1,986,231,480.13 元。 上述募集资金已于 2024 年 1 月 9 日全部到账，天健会计师事务所（特殊普 通合伙）对本次募集资金到位情况进行了审验，并于 2024 年 1 月 10 日出具验资 报告（天健验〔2024〕15 号）。公司已对上述募集资金进行了专户存储，并会 同保荐机构与相关开户银行签订了《募集资金专户存储三方监管协议》。 开源证券股份有限公司 关于浙江东南网架股份有限公司 使用部分闲置募集资金暂时补充流动资金之核查意见 开源证券股份有限公司（以下简称"开源证券"、"保荐机构"）作为浙江 东南网架股份有限公司（以下简称"东南网架 ...

Core Viewpoint - The company intends to temporarily use part of the idle raised funds to supplement its working capital, ensuring that this does not affect the normal progress of the fundraising investment projects [1][4][6] Summary of Fundraising Situation - The company issued 2,430,000 convertible bonds at a price of 100 yuan each, raising a total of 243 million yuan, with a net amount of approximately 238.63 million yuan after deducting issuance costs [1] - The funds have been deposited in a dedicated account, and a tripartite supervision agreement has been signed with the sponsoring institution and the bank [1] Summary of Investment Projects and Idle Funds - The total investment for the projects is 250 million yuan, with 243 million yuan planned to be used from the raised funds [2] - Due to the construction cycle of the investment projects, some funds are temporarily idle, and the company plans to use these idle funds for working capital without changing the purpose of the raised funds [2][5] Previous Use of Idle Funds - The company previously used 51.8 million yuan of idle funds to supplement working capital, which has been fully returned to the dedicated account within the stipulated 12 months [3] Current Plan for Using Idle Funds - The company plans to use up to 60 million yuan of idle funds for working capital, with a usage period not exceeding 12 months from the board's approval date [4][5] Approval Process - The board of directors and the supervisory board have approved the use of idle funds, confirming that it will not affect the investment projects and complies with relevant regulations [5][6]

核查意见 华泰联合证券有限责任公司 关于安徽华人健康医药股份有限公司使用闲置募集资金临 时补充流动资金的核查意见 华泰联合证券有限责任公司（以下简称"华泰联合证券"或"保荐人"）作 为安徽华人健康医药股份有限公司（以下简称"华人健康"或"公司"）首次公 开发行股票并在创业板上市持续督导阶段的保荐人，根据《证券发行上市保荐业 务管理办法》《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监 管要求》 《深圳证券交易所创业板股票上市规则》 《深圳证券交易所上市公司自律 监管指引第 2 号——创业板上市公司规范运作》及《深圳证券交易所上市公司自 律监管指引第 13 号——保荐业务》等有关规定，对华人健康使用闲置募集资金 临时补充流动资金事项进行了核查，具体核查情况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意安徽华人健康医药股份有限公司首次 公开发行股票注册的批复》（证监许可20222406 号）同意注册，公司获准向社 会公众发行人民币普通股 A 股 6,001.00 万股，每股面值人民币 1 元。截至 2023 年 3 月 1 日止，公司已向社会公众发行人民币普通股 A 股 6,001 ...

股票代码：002728 股票简称：特一药业 公告编号：2025-033 特一药业集团股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 特一药业集团股份有限公司（以下简称"特一药业"或"公司"）于 2025 年 5 月 资金暂时补充流动资金的议案》，现就使用可转债部分闲置募集资金暂时补充流动资金 的相关事宜公告如下： 一、募集资金基本情况 经中国证券监督管理委员会证监许可20172004 号文《关于核准特一药业集团股份 有限公司公开发行可转换公司债券的批复》核准，公司获准于 2017 年 12 月 6 日向社会 公开发行 3,540,000 张可转换公司债券，每张面值 100 元，发行总额 354,000,000.00 元。 公司发行可转债募集资金总额为人民币 354,000,000.00 元，利息为 12,776.67 元， 扣除承销费用、保荐费人民币 6,000,000.00 元后的发行金额 348,012,776.67 元，已由 保荐人（主承销商）于 2017 年 12 月 12 日汇入本公司募集资金专项存储账户内。另扣 除律师、会计师、资信评 ...

股票代码：002728 股票简称：特一药业 公告编号：2025-032 特一药业集团股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 特一药业集团股份有限公司（以下简称"公司"）第五届监事会第二十八次会议于 以通讯或书面方式发出。会议应出席监事 3 名，实际出席监事 3 名，会议的召集、召开 符合《公司法》和《公司章程》规定。 会议由公司监事会主席张名坚先生主持。与会监事审议了有关议案，一致通过以下 决议： 一、审议通过《关于使用可转债部分闲置募集资金暂时补充流动资金的议案》 （表决结果：同意票 3 票，反对票 0 票，弃权票 0 票） 二、审议通过《关于使用非公开发行部分闲置募集资金暂时补充流动资金的议案》 公司已归还前次使用非公开发行部分闲置募集资金暂时补充流动资金的募集资金。 监事会同意公司在保证 2021 年非公开发行股票募集资金投资项目的资金需求前提下使 用 不 超 过 人 民 币 1,500 万 元 （ 占 公 司 2021 年 非 公 开 发 行 股 票 募 集 资 金 净 额 董事会第三十二次会议审议通过后，自首次办理暂时补充流动 ...

Core Points - The company held its 21st temporary meeting of the 8th Supervisory Board on May 21, 2025, where all three attending supervisors unanimously approved the proposal to open a special account for temporarily supplementing working capital with idle raised funds [1][2] - The company plans to use up to 181 million yuan of idle raised funds to temporarily supplement its working capital, ensuring compliance with regulatory requirements and protecting investors' rights [2] Group 1 - The meeting was legally valid with three supervisors present, meeting the required quorum [1] - The proposal to open a special account for the management of idle raised funds was passed with a unanimous vote of 3 in favor [1][2] - The company will sign a regulatory agreement with the sponsoring institution and the bank to oversee the storage and use of the raised funds [2]